New ADHD pill for kids shows promise in major trial
NCT ID NCT05428033
First seen Apr 14, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study tested a once-daily medication called centanafadine in 574 children aged 4 to 12 with ADHD. The goal was to see if it reduces ADHD symptoms better than a placebo over 6 weeks. Researchers measured changes in symptom scores and overall severity to determine effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
For additional information regarding sites, contact 844-687-8522
New York, New York, 10012, United States
Conditions
Explore the condition pages connected to this study.